Skip to content

Relationship between donor / recipient compatibility and human microbiome in fecal microbiota transplantation for patients with ulcerative colitis.

Relationship between donor / recipient compatibility and human microbiome in fecal microbiota transplantation for patients with ulcerative colitis. - Relationship between donor / recipient compatibility and human microbiome in fecal microbiota transplantation for patients with ulcerative colitis.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049899
Enrollment
210
Registered
2022-12-26
Start date
2021-06-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients and stool donors who participated in the preceding clinical studies "Evaluation of the effectiveness of fecal transplantation and fecal transplantation combined with oral antibiotic (AFM therapy) in patients with ulcerative colitis" and "Evaluation of the effectiveness of fecal transplantation and antibiotics in patients with ulcerative colitis" and "Evaluation of the effectiveness of fecal transplantation and antibiotics in patients with inflammatory bowel diseases and its factors".

Exclusion criteria

Exclusion criteria: Patients deemed unsuitable as subjects by the principal investigator.

Design outcomes

Primary

MeasureTime frame
-

Countries

Japan

Contacts

Public ContactDai Ishikawa

Juntendo University Hospital Department of Gastroenterology

dai@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026